Semaglutide is a GLP-1 receptor agonist used primarily for the treatment of type 2 diabetes and obesity. It mimics the action of the naturally occurring hormone GLP-1, which helps regulate blood sugar levels and appetite. Semaglutide has gained widespread recognition for its effectiveness in promoting significant weight loss and improving glycemic control.
Approved by the FDA, Semaglutide has been shown in clinical trials to reduce HbA1c levels and body weight substantially. Its once-weekly dosing schedule makes it a convenient option for patients seeking long-term metabolic management. The medication works by enhancing insulin secretion, suppressing glucagon release, and slowing gastric emptying.